Immunogen (IMGN) Director Buys 20K Shares
Get Alerts IMGN Hot Sheet
Join SI Premium – FREE
Immunogen (NASDAQ: IMGN) Director, Mark Alan Goldberg, bought 20,000 shares on 12/15 at $1.80
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman is bullish on this stock given ‘significant leverage’ to the AI infra build-out
- Delta Air Lines Q2 earnings preview: softer profit expected amid fuel price headwinds
- Bernstein makes 3 tactical stock calls into Q2 earnings
Create E-mail Alert Related Categories
Insiders' BlogSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share